0 Yorumlar
0 hisse senetleri
1K Views
0 önizleme
Site içinde arama yapın
Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek
-
Please log in to like, share and comment!
-
Biosimilars and Biologics Market to Hit USD 35.4B by 2030, Says DataM IntelligenceMarket Overview The Biosimilars and Biologics Market size reached US$531.45 billion in 2024 and is expected to reach US$1,773.77 billion by 2033, growing at a CAGR of 14.4% during the forecast period 2025-2033. The Biosimilars and Biologics Market is booming amid rising chronic diseases and aging populations. These therapies provide targeted treatments for complex conditions like cancer and...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
-
Biosimilars Market Gaining Traction Due to Cost-Effective Treatment OptionsBiosimilars Market Drivers and Trends The surge in chronic diseases such as cancer, diabetes, and autoimmune disorders has heightened the need for affordable therapeutic options. Biosimilars, being cost-effective alternatives to original biologic drugs, offer significant savings for healthcare systems and patients. Additionally, the expiration of patents for several blockbuster biologics...0 Yorumlar 0 hisse senetleri 3K Views 0 önizleme
-
Biosimilars Market Outlook: Transforming the Future of Cost-Effective HealthcareBiosimilars Market was valued at US$ 21 Bn. in 2022. Global Biosimilars Market size is expected to grow at a CAGR of 16.72 % through the forecast period. Global Biosimilars Market Overview The global Biosimilars Market has emerged as a transformative segment within the pharmaceutical and biotechnology industries. Valued at US$ 21 billion in 2022, the market is projected to expand...0 Yorumlar 0 hisse senetleri 227 Views 0 önizleme
-
Biosimilars Market Outlook: Transforming the Future of Cost-Effective HealthcareBiosimilars Market was valued at US$ 21 Bn. in 2022. Global Biosimilars Market size is expected to grow at a CAGR of 16.72 % through the forecast period. Global Biosimilars Market Overview The global Biosimilars Market has emerged as a transformative segment within the pharmaceutical and biotechnology industries. Valued at US$ 21 billion in 2022, the market is projected to expand...0 Yorumlar 0 hisse senetleri 214 Views 0 önizleme
-
HER2 Antibodies Market by Type (Monoclonal, Biosimilars), Application (Breast, Gastric Cancer), End-UserHER2 Antibodies Market was valued USD 9.37 Bn in 2023 and is expected to reach USD 13.19 Bn by 2030, at a CAGR of 5.0%. HER2 Antibodies Market Overview: Maximize Market Research is a Business Consultancy Firm that has published a detailed analysis of the “HER2 Antibodies Market”. The report includes key business insights, demand analysis, pricing analysis, and competitive...0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme
-
HER2 Antibodies Market by Type (Monoclonal, Biosimilars), Application (Breast, Gastric Cancer), End-UserHER2 Antibodies Market was valued USD 9.37 Bn in 2023 and is expected to reach USD 13.19 Bn by 2030, at a CAGR of 5.0%. HER2 Antibodies Market Overview: Maximize Market Research is a Business Consultancy Firm that has published a detailed analysis of the “HER2 Antibodies Market”. The report includes key business insights, demand analysis, pricing analysis, and competitive...0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme
-
Herceptin Biosimilars Market Regional DistributionPolaris Market Research has introduced the latest market research report titled Herceptin Biosimilars Market Size, Share, Trends, Industry Analysis Report: By Application (Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, and Others), Dosage, End-Users, Distribution Channel, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market...0 Yorumlar 0 hisse senetleri 655 Views 0 önizleme
-
Herceptin Biosimilars Market Regional DistributionPolaris Market Research has introduced the latest market research report titled Herceptin Biosimilars Market Size, Share, Trends, Industry Analysis Report: By Application (Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, and Others), Dosage, End-Users, Distribution Channel, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market...0 Yorumlar 0 hisse senetleri 633 Views 0 önizleme
-
What Is the Market Outlook for Biosimilars in the Anticancer Drug Segment?Anticancer Drugs Market Poised for Robust Growth Through 2030 The global anticancer drugs market is experiencing significant expansion, with projections estimating an increase from USD 222.57 billion in 2023 to USD 495.07 billion by 2030. This growth represents a compound annual growth rate (CAGR) of 12.1% during the forecast period. Curious to peek inside? Grab your sample copy of...0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
